Hongyu Luo

1.5k total citations · 2 hit papers
38 papers, 1.1k citations indexed

About

Hongyu Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hongyu Luo has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hongyu Luo's work include Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (3 papers) and Cardiac Imaging and Diagnostics (2 papers). Hongyu Luo is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (3 papers) and Cardiac Imaging and Diagnostics (2 papers). Hongyu Luo collaborates with scholars based in China, Canada and United States. Hongyu Luo's co-authors include Hui‐Zhi Long, Lichen Gao, Ziwei Zhou, Dan‐Dan Wen, Shuo‐Guo Xu, Feng‐Jiao Li, Yan Cheng, Wen‐Mei Yu, Jun He and Yunmei Liu and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Hongyu Luo

36 papers receiving 1.1k citations

Hit Papers

PI3K/AKT Signal Pathway: A Target of Natural Products in ... 2021 2026 2022 2024 2021 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
    2021 321 citations Hui‐Zhi Long, Ziwei Zhou et al. Frontiers in Pharmacology profile →
  2. System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
    2022 272 citations Feng‐Jiao Li, Hui‐Zhi Long et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyu Luo China 12 498 292 245 141 93 38 1.1k
Hong Xin China 25 829 1.7× 126 0.4× 205 0.8× 166 1.2× 64 0.7× 54 1.6k
Ming‐Wei Lin Taiwan 24 734 1.5× 110 0.4× 161 0.7× 65 0.5× 51 0.5× 70 1.4k
Yousheng Mo China 15 324 0.7× 177 0.6× 133 0.5× 139 1.0× 115 1.2× 24 775
Wen‐Jun Duan China 23 682 1.4× 362 1.2× 253 1.0× 119 0.8× 66 0.7× 32 1.4k
Monika Barteková Slovakia 22 688 1.4× 128 0.4× 269 1.1× 205 1.5× 39 0.4× 57 1.6k
Huiqin Zhong China 8 464 0.9× 141 0.5× 154 0.6× 116 0.8× 24 0.3× 8 955
Hui‐Zhi Long China 11 499 1.0× 271 0.9× 252 1.0× 130 0.9× 81 0.9× 16 904
Yinan Luo China 20 804 1.6× 245 0.8× 274 1.1× 69 0.5× 77 0.8× 32 1.3k
Sijin Yang China 18 489 1.0× 121 0.4× 123 0.5× 46 0.3× 104 1.1× 75 981

Countries citing papers authored by Hongyu Luo

Since Specialization
Citations

This map shows the geographic impact of Hongyu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyu Luo more than expected).

Fields of papers citing papers by Hongyu Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyu Luo. The network helps show where Hongyu Luo may publish in the future.

Co-authorship network of co-authors of Hongyu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyu Luo. A scholar is included among the top collaborators of Hongyu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyu Luo. Hongyu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duan, Xiangrui, Yuanjian Li, Guocheng Li, et al.. (2025). Stress‐Mediated Dynamic Li Plating in Practical Li Metal Pouch Cells. Advanced Functional Materials. 35(52). 1 indexed citations
3.
Luo, Hongyu, Pan Liu, Xin Deng, et al.. (2025). Mass-produced anti-fogging films with excellent performances formed from amphiphilic random copolymers via roll-to-roll coating. Progress in Organic Coatings. 200. 109089–109089. 1 indexed citations
4.
Duan, Xiangrui, Yuanjian Li, Kai Huang, et al.. (2025). Revealing ionically isolated Li loss in practical rechargeable Li metal pouch cells. Science Bulletin. 70(6). 914–922. 6 indexed citations
5.
6.
Long, Hui‐Zhi, et al.. (2024). Isoliensinine activated the Nrf2/GPX4 pathway to inhibit glutamate‐induced ferroptosis in HT‐22 cells. Journal of Biochemical and Molecular Toxicology. 38(9). e23794–e23794. 6 indexed citations
7.
Long, Hui‐Zhi, et al.. (2024). Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma. Journal of Pharmacy and Pharmacology. 77(6). 752–767. 1 indexed citations
8.
Luo, Hongyu, et al.. (2024). Combined use of Panax notoginseng and leech provides new insights into renal fibrosis: Restoration of mitochondrial kinetic imbalance. PLoS ONE. 19(5). e0303906–e0303906. 1 indexed citations
9.
Zhou, Ziwei, Hui‐Zhi Long, Shuo‐Guo Xu, et al.. (2022). Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways. Frontiers in Pharmacology. 13. 899208–899208. 20 indexed citations
10.
11.
Luo, Hongyu, Ke Xu, Yin Shi, et al.. (2022). Effect of Fushengong Decoction on PTEN/PI3K/AKT/NF-κB Pathway in Rats With Chronic Renal Failure via Dual-Dimension Network Pharmacology Strategy. Frontiers in Pharmacology. 13. 807651–807651. 7 indexed citations
12.
Luo, Hongyu, Hui‐Zhi Long, Ziwei Zhou, et al.. (2022). Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions. Drugs in R&D. 22(4). 311–320. 3 indexed citations
13.
Luo, Hongyu, Jiangwei Yang, Huanhuan Zhang, et al.. (2021). The Effect of Stu-miR156 Silencing by STTM Technology on Potato Lateral Root Development. Acta Horticulturae Sinica. 48(3). 531. 2 indexed citations
14.
Yang, Wei, et al.. (2021). Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review. Aging and Disease. 12(3). 841–841. 23 indexed citations
15.
Luo, Hongyu, et al.. (2021). Sublingual immunotherapy in mite-sensitized patientswith atopic dermatitis: a randomized controlled study. Advances in Dermatology and Allergology. 38(1). 69–74. 5 indexed citations
16.
Wang, Gang, Qi Hua, Jing Li, et al.. (2016). Does SYNTAX score II predict poor myocardial perfusion in ST-segmen. Cardiology Journal. 23(3). 317–323. 2 indexed citations
17.
Luo, Hongyu, et al.. (2016). Association study of clusterin polymorphism rs11136000 with late-onset Alzheimer's disease in Bai population. Zhonghua xingwei yixue yu naokexue zazhi. 25(3). 240–243. 1 indexed citations
18.
Lei, Jianhua, Yi Tian, Hongyu Luo, Zi Chen, & Feng Peng. (2016). Guillain–Barré syndrome following acute co‐super‐infection of hepatitis E virus and cytomegalovirus in a chronic hepatitis B virus carrier. Journal of Medical Virology. 89(2). 368–372. 11 indexed citations
19.
Zhu, Weiwei, Jing Li, Hongyu Luo, Gang Wang, & Qi Hua. (2015). Comparison of 2-year outcomes of repeated second-generation drug-eluting stent implantation for focal-type versus nonfocal-type in-stent restenosis. Coronary Artery Disease. 26(7). 587–591. 3 indexed citations
20.
Chen, Huifang, Jiangping Wu, Dasheng Xu, Hongyu Luo, & Pierre Daloze. (1993). REVERSAL OF ONGOING HEART, KIDNEY, AND PANCREAS ALLOGRAFT REJECTION AND SUPPRESSION OF ACCELERATED HEART ALLOGRAFT REJECTION IN THE RAT BY RAPAMYCIN. Transplantation. 56(3). 661–666. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Xin Breakdown of academic impact, for papers by Ming‐Wei Lin Breakdown of academic impact, for papers by Yousheng Mo Breakdown of academic impact, for papers by Wen‐Jun Duan Breakdown of academic impact, for papers by Monika Barteková Breakdown of academic impact, for papers by Huiqin Zhong Breakdown of academic impact, for papers by Hui‐Zhi Long Breakdown of academic impact, for papers by Yinan Luo Breakdown of academic impact, for papers by Sijin Yang
Rankless by CCL
2026